2026-08-10 · TIRZEPATIDE · TopGLP1Providers Data Desk
The cheapest compounded tirzepatide online right now, explained in plain words
As of the 2026-08-09 capture, the cheapest verified, all-in monthly price for compounded tirzepatide from a US telehealth program is $215 a month at NexLife↗ — the same price at every dose from 2.5 mg through 15 mg, with no membership fee and shipping and clinician services included. The next-cheapest verified program is Yucca Health↗ at $258 a month, then IVIM Health↗ and Mochi Health↗ at $278 a month all-in. The lowest advertised starting price in the index is $133 at Fifty 410, but that is a starter-dose figure with no published maintenance price, which is exactly the kind of number this article exists to unpack.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
This page deliberately gives you the market in sentences rather than a grid, because a grid is where the important qualifiers go to die. A price for compounded tirzepatide is only meaningful once you know four things about it: whether it is the price at your maintenance dose or only at the starter dose, whether a mandatory membership sits on top of it, whether it requires prepaying months in advance, and when it was last read from the provider's own page. Every figure below carries those answers with it.
Where the verified floor actually sits
Start with the number that survives all four tests. NexLife charges $215 a month for compounded tirzepatide, month-to-month, at every dose. There is no membership on top, no separate consultation fee, and no shipping charge; the $215 is the billed total. Because the price is dose-flat, the 10 mg maintenance basis we rank on costs the same as the 2.5 mg starter — which matters more than it sounds, since most people who stay on tirzepatide do not stay at 2.5 mg. If you are willing to prepay, NexLife's twelve-month rate works out to $186 a month, billed as $2,232 upfront — a prepaid commitment, not monthly billing, and you should treat it that way when you compare.
One step up the ladder, Yucca Health comes in at $258 a month all-in and dose-flat, also without a membership line. Then comes a cluster in the high two-hundreds: IVIM Health at $278 all-in (a $75 platform fee is inside that figure), Mochi Health at $278 all-in (medication plus a mandatory $79 monthly membership — the advertised medication price alone is not what you pay), and ShedRx↗ and Found at $289. SkinnyRx↗ sits at $299, and OrderlyMeds↗ states $299 publicly, though at our capture date we could not confirm that figure on a pricing page at the provider itself, so it carries a stated-not-verified flag in the database.
From there the market climbs quickly: Henry Meds↗ and TrimRx↗ at $349 a month, Remedy Meds↗ and MEDVi↗ at $399, Eden at $408 once its $99 membership is folded in, and LifeMD↗ at $597 all-in at the top of the compounded index. The verified compounded market, in other words, spans roughly $215 to $597 a month for what is nominally the same molecule — a $382-a-month spread that comes almost entirely from program structure, not pharmacology.
Why the very cheapest number you saw in an ad is probably not your price
The single most common pricing trick in this category is the starter-dose teaser. Fifty 410 advertises tirzepatide from $133 a month — genuinely the lowest advertised figure we track — but publishes no maintenance-dose price we could capture. If the price rises with the dose and you titrate on the standard schedule, the number you saw in month one tells you very little about month six. That is why our ranking basis is the all-in price at the 10 mg maintenance dose: it is the number you will actually live with. Any program that will not state that number in writing has not really quoted you a price.
The second trick is the unbundled membership. A $99 medication price with a mandatory $79 membership is not a $99 program; it is a $178 program. We fold every mandatory recurring fee into the figures above so the comparison is honest, and we say so on every page where a membership is doing quiet work inside a headline price.
The third is the prepaid quote presented as a monthly price. "$186 a month" and "$2,232 billed today" are the same offer wearing different clothes. Prepaid rates are real savings — over a year, NexLife's prepaid path is $348 cheaper than its own month-to-month billing — but a prepaid rate should never be compared against another provider's month-to-month rate as if they were the same kind of number.
The 2026 legal context you cannot skip
Compounded tirzepatide in 2026 is not the open market it was in 2023–2024. The FDA declared the tirzepatide shortage resolved in late 2024; enforcement discretion for pharmacies ended in early 2025 (February 18, 2025 for 503A pharmacies and March 19, 2025 for 503B outsourcing facilities); a federal court upheld the FDA's position in May 2025; and on April 30, 2026 the agency proposed removing tirzepatide, semaglutide, and liraglutide from the 503B bulk-compounding list entirely. What remains is a narrow lane: patient-specific prescriptions filled at state-licensed 503A pharmacies where the prescriber documents a clinical reason an FDA-approved product cannot meet. Telehealth programs still operating in this category are operating in that lane — and you should expect any legitimate one to ask real screening questions and to name the pharmacies that fill its prescriptions. Our full regulatory explainer covers what changed, date by date.
That context also reframes "cheapest." Brand-name tirzepatide is now closer than it used to be: Eli Lilly's own LillyDirect↗ channel sells Zepbound single-dose vials to cash-pay patients from $299 a month at the starter dose, and $449 a month at the 7.5–15 mg doses if you refill within Lilly's 45-day window. At maintenance, the gap between the cheapest verified compounded program and the FDA-approved product is about $234 a month — real money, but no longer a category difference, and the approved product comes with manufacturing oversight that compounded copies do not. If insurance might cover you, that changes the math entirely, and a coverage-first program like Ro is the better starting point. We keep a dedicated comparison of those two paths.
Five things to get in writing before you pay anyone
Whichever program you choose — including the cheapest one — get five answers in writing before the first charge. First, the exact all-in monthly price at your dose, and at the 10 mg maintenance dose, with membership included. Second, the full upfront amount being billed today, and whether it recurs monthly or is a prepaid term. Third, which licensed pharmacy fills the prescription, and whether it is a 503A pharmacy or an FDA-registered 503B facility. Fourth, the cancellation and refund terms, especially for anything prepaid. Fifth, the capture-worthy detail almost nobody asks: what happens to your price when your dose changes. Dose-flat programs like NexLife and Yucca make that last answer trivial; tiered programs make it the whole ballgame.
Every number in this article was read from provider pages on the dates shown in the price database, where each record carries its capture date, its source link, and an archive link. When a figure changes, the database changes, this article's numbers change with it, and the diff lands in the changelog. If you find a price we have wrong, tell us — corrections are logged publicly.
Compounded tirzepatide is not an FDA-approved product. Nothing here is medical advice; whether any GLP-1 is appropriate for you is a decision for you and a licensed clinician.